Miri Wernli
President presso MIND MEDICINE (MINDMED)
Patrimonio netto: 468 352 $ in data 29/02/2024
Profilo
Miri Halperin Wernli founded Melodiol Global Health Ltd.
She is Executive President at Mind Medicine (MindMed), Inc.
She previously held the position of Executive Director, Head-Technology & Innovation at Melodiol Global Health Ltd.
and Vice President for Actelion Pharmaceuticals US, Inc.
She received a doctorate from the University of Geneva and an MBA from Stanford University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
27/02/2024 | 81 353 ( 0.12% ) | 464 932 $ | 29/02/2024 | |
29/03/2023 | 750 000 ( 0.19% ) | 3 420 $ | 29/02/2024 |
Posizioni attive di Miri Wernli
Società | Posizione | Inizio |
---|---|---|
MIND MEDICINE (MINDMED) | President | 01/02/2021 |
Precedenti posizioni note di Miri Wernli
Società | Posizione | Fine |
---|---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Corporate Officer/Principal | 01/01/2016 |
MELODIOL GLOBAL HEALTH LIMITED | Chief Executive Officer | 15/08/2020 |
Formazione di Miri Wernli
Stanford University | Masters Business Admin |
University of Geneva | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
MELODIOL GLOBAL HEALTH LIMITED | Health Technology |
MIND MEDICINE (MINDMED) | Health Technology |
Aziende private | 1 |
---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |